DarioHealth
DRIO
13 hedge funds and large institutions have $4.7M invested in DarioHealth in 2018 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 4 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
100% more capital invested
Capital invested by funds: $2.35M → $4.7M (+$2.34M)
0.01% more ownership
Funds ownership: 0.03% → 0.04% (+0.01%)
7% less funds holding
Funds holding: 14 → 13 (-1)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$3.01M |
| 2 |
MIM
Marco Investment Management
Atlanta,
Georgia
|
+$22.2K |
| 3 |
Goldman Sachs
New York
|
+$20.1K |
| 4 |
BlackRock
New York
|
+$17.6K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$8.97K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$48K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$17K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$13K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$8K |
| 5 |
BA
Bard Associates
Chicago,
Illinois
|
-$3.23K |
DRIO Hedge Fund Activity: Q4 2018 in Review
13 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in DarioHealth (DRIO) for Q4 2018, worth a combined $4.7M — up 100% from $2.35M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of DRIO and 3 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 2 added.
The largest buyer was Nantahala Capital Management, opening a new position worth an estimated $3.01M. The largest seller was Susquehanna International Group, exiting entirely with an estimated $48K sold.
- 13 institutional investors held DarioHealth (DRIO) as of Q4 2018, down from 14 in Q3 2018.
- Funds reported $4.7M of DarioHealth stock for Q4 2018, up 100% quarter-over-quarter.
- 3 funds opened new DarioHealth positions in Q4 2018 and 4 closed out, a net change of -1 holder.
- The largest DarioHealth buyer in Q4 2018 was Nantahala Capital Management, an estimated $3.01M added.
- The largest DarioHealth seller in Q4 2018 was Susquehanna International Group, an estimated $48K sold.
Based on aggregated 13F filings for Q4 2018.